// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

Inter-rater reliability of the UK Department of Health VTE risk assessment tool for medical and surgical hospital admissions

D. Horner - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Interim Analysis from B-MORE, a 24-month Prospective, Multicentre, Non-interventional Study on Effectiveness and Usage of Recombinant Factor IX Fc (rFIXFc) in Haemophilia B

H. Glosli - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Hemophilia

N/A

Investigating the health and function of murine platelets generated using a new ex-vivo lung system

N. Tarassova - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Phosphatidylserine

Investigation of Podoplanin Signalling Complexes in Primary Lymphatic Endothelial Cells

T. AL THUNAYAN - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Iron deficiency reduces mitochondrial respiration in skeletal muscle

K. Cabolis - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Left atrium size is associated with fibrin clot ultrastructure in patients with acute myocardial infarction

A. Siniarski - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Myocardial infarction

Fibrinogen (IV)

Leptin and IL-6 are linked to the mechanism underlying the prothrombotic state in obese pregnant women

S. McNeill - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Fibrinogen (IV)

Lineage specific vascular smooth muscle cell differentiation from pluripotent stem cells: A developmental bias towards aortic calcification

A. Akbulut - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Aortic valve calcification

stannous fluoride

Little discrepancy of one-stage and chromogenic assays in a large international cohort of patients with non-severe hemophilia A and B (DYNAMO study)

A. Zwagemaker - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Hemophilia

FVIII

Local experience of monitoring and effectiveness of Emicizumab in severe Haemophilia A

J. Needham - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Hemophilia

Evithrom

Longitudinal kinetics of B-cell subsets in Immune Thrombotic Thrombocytopenic Purpura Patients: Relapses vs Remission

M. Subhan - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Thrombotic thrombocytopenic purpura

Rituximab

Loss of function variant in SMIM1 is associated with reduced energy expenditure, weight gain and an increased risk for cardiovascular events.

L. Stefanucci - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Low ADAMTS13 activity rapid assay results in patients with low clinical probability of Thrombotic Thrombocytopaenic Purpura (TTP) – the United Kingdom experience

S. MacDonald - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Low level mosaicism in a boy with mild haemophilia A excludes his mother as a carrier.

M. Mitchell - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Hemophilia

FVIII

Low molecular weight heparin slows the formation of clots from patients within twenty-four hours of acute PE

S. Baker - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Heparin

Measurement of fibrinogen using two concentrations of Thrombin with patients receiving Argatroban or normal plasma spiked with Argatroban: a review of UK NEQAS (Blood Coagulation) exercises 2021.

C. Reilly-Stitt - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Fondaparinux sodium

Mechanical Injury of a tissue-engineered human arterial construct replicates the thrombotic and pharmacological properties of the native artery.

J. Ranjbar - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Medically Recorded Bleeds and Healthcare Resource Use in the United States Among Adult Males With Hemophilia A

L. Markson - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Gastrointestinal bleeding

FVIII

Method and laboratory specific clinical cut-offs support appropriate interpretation of ADAMTS13 activity assays

S. MacDonald - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Method Discrepant ADAMTS-13 activity results in first presentation query TTP subjects

T. Pitchford - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Copyright © 2026. QuantiNova All rights reserved